CXCR2 and pancreatic neoplasm: This study reveals that CXCR2-mediated neutrophil infiltration and NET formation escalate with pancreatic cancer progression, are enhanced by gemcitabine chemotherapy, contribute to an immunosuppressive microenvironment, and are linked to reduced patient survival.